Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiplatelet therapy after left atrial appendage closure (SAFE-LAAC)
NCT03445949Phase 4Recruiting
- Sponsor
- National Institute of Cardiology
- Start
- Jan 2018
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel, aspirin in Atrial fibrillation (AFib), sponsored by National Institute of Cardiology. Started Jan 2018; status: recruiting.
02
Drugs
clopidogrelaspirin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03445949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03445949.